We once thought lung cancer, like many cancers, was one disease. We now know that if you examine the cells from a given lung tumor, many different mutations may be present. Therefore, the ‘molecular fingerprint’ of tumors differ and require different treatments....
Last week we held a Tweet Chat with our amazing co-hosts Georgia Hurst and Amy Byer Shainman, and special guest Timothy Rebbeck, PhD of the Dana-Farber Cancer Institute to discuss what’s happening in the BRCA...
We recently sat down with Howard Look, President and CEO of Tidepool.org, a San Francisco-based non-profit, open source development organization dedicated to reducing the burden for people with Type 1 Diabetes. Here’s what he had to say about his organization,...
A major component of the Precision Medicine Initiative (PMI), announced by President Obama in January, is the PMI Cohort Program (PMI-CP) – a new research cohort of a million or more volunteer participants. This research cohort will help to expand our knowledge and...
Last week the Precision Medicine Initiative (PMI) Working Group of the Advisory Committee to the NIH Director (ACD) hosted a public workshop on Mobile and Personal Technologies in Precision Medicine in Santa Clara, CA. Over the course of two days,...
